Search - tctmd.com

Displaying 21 - 40 of 127

Sort: Relevancy | Date

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Daily News

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Yael L. Maxwell

May 22, 2020

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

Caitlin E. Cox

May 15, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Daily News

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Michael O'Riordan

March 26, 2020

News Daily News

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Caitlin E. Cox

March 18, 2020

News Daily News

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

Michael O'Riordan

January 27, 2020

News Daily News

For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI

L.A. McKeown

January 13, 2020

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Daily News

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Michael O'Riordan

July 30, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

News Daily News

Many PCI Patients Treated in China Have No Angina Symptoms

Caitlin E. Cox

December 20, 2018

Advertisement

PCI Volumes Rise in US and Japan, but for Different Reasons

July 2020 News Roundup

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

More Adverse Events, Higher Costs With Impella: New Observational Studies

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Many PCI Patients Treated in China Have No Angina Symptoms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content